ADA 2026 5 - 8 June 2026

Semaglutide Reduces Asthma-Related Adverse Outcomes in Patients With Comorbid Asthma and Obesity: A Post Hoc Analysis of the SELECT Trial

Authors :

Charlotte Suppli Ulrik¹²; Kjell Erik Julius Håkansson¹; Søren Rasmussen³; Miquel Triana Iglesias³; Howraman Meteran¹⁴; Robert Kushner⁵; Kasper Adelborg³; Signe Stensen³; Lotte Bjerre Knudsen⁶; Sheila Tuyet Tang³

Affiliations

View Details Hide Details

Download .PDF

Keywords

Obesity

Cardiovascular Disease

Congress poster

GLP-1 RA

Semaglutide

PHASE 3 (RCT)

Search Science Hub

Are you a healthcare professional?

Semaglutide Reduces Asthma-Related Adverse Outcomes in Patients With Comorbid Asthma and Obesity: A Post Hoc Analysis of the SELECT Trial